Abstract:Accurate staging improves lung cancer survival by increasing the chances of delivering stage‐appropriate therapy. However, there is underutilization of, and variability in, the use of guideline‐recommended diagnostic tests used to stage lung cancer. Consequently, the American Cancer Society National Lung Cancer Roundtable (ACS NLCRT) convened the Triage for Appropriate Treatment Task Group—a multidisciplinary expert and stakeholder panel—to identify knowledge and/or resource gaps contributing to guideline‐discordant staging and make recommendations to overcome these gaps. The task group determined the following: Gap 1: facilitators of and barriers to guideline‐concordant staging are incompletely understood; Recommendation 1: identify facilitators of and barriers to guideline‐concordant lung cancer staging; Gap 2: the level of evidence supporting staging algorithms is low‐to‐moderate; Recommendation 2: prioritize comparative‐effectiveness studies evaluating lung cancer staging; Gap 3: guideline recommendations vary across professional societies; Recommendation 3: harmonize guideline recommendations across professional societies; Gap 4: existing databases do not contain sufficient information to measure guideline‐concordant staging; Recommendation 4: augment existing databases with the information required to measure guideline‐concordant staging; Gap 5: health systems do not have a performance feedback mechanism for lung cancer staging; Recommendation 5: develop and implement a performance feedback mechanism for lung cancer staging; Gap 6: patients rarely self‐advocate for guideline‐concordant staging; Recommendation 6: increase opportunities for patient self‐advocacy for guideline‐concordant staging; and Gap 7: current health policies do not motivate guideline‐concordant lung cancer staging; Recommendation 7: organize a representative working group under the ACS NLCRT that promotes policies that motivate guideline‐concordant lung cancer staging. Plain language summary Staging—determining the degree of cancer spread—is important because it helps clinicians choose the best cancer treatment. Receiving the best cancer treatment leads to the best possible patient outcomes. Practice guidelines are intended to help clinicians stage patients with lung cancer. However, lung cancer staging in the United States often varies from practice guideline recommendations. This report identifies seven opportunities to improve lung cancer staging.

Guideline of surgical practice for non-small cell lung cancer based staging

Real-world Surgical Treatment Patterns and Clinical Outcomes in Patients with Stages IA–IIIA Non-Small Cell Lung Cancer: a Retrospective Multicentric Observational Study Involving 11,958 Patients

Expert Consensus on Treatment for Stage III Non‐small Cell Lung Cancer

Preoperative Lymph Node Assessment in Surgically Resected Pathologic T1 Lung Cancer Patients: Real World Clinical Practice in China.

Surgical Treatments of Chinese Patients with Lung Malignant Tumors.

[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2023 edition)]

Wedge Resection of Pulmonary Nodules(≤2 Cm):A Consensus Statement by Specialists of Thoracic Surgery(2023 Edition)

Society for Translational Medicine consensus on postoperative management of EGFR-mutant lung cancer (2019 edition)

[Chinese Medical Association guideline for clinical diagnosis and treatment of lung cancer (2024 edition)]

Management Guidelines for Primary Lung Cancer 2018: Chinese Standards in Clinical Practice

Development And Validation Of A Surgical-Pathologic Staging And Scoring System For Cervical Cancer

Chinese Society of Clinical Oncology (CSCO) Breast Cancer guidelines 2024

The Chinese Society of Clinical Oncology (CSCO): Clinical guidelines for the diagnosis and treatment of gastric cancer, 2021

The American Cancer Society National Lung Cancer Roundtable strategic plan: Promoting guideline‐concordant lung cancer staging

Quality control analysis of surgical treatment of lung cancer: a single center's experience

A critical appraisal of clinical practice guidelines on surgical treatments for spinal metastasis

Clinical Pathway for Surgical Treatment of Primary Lung Cancer (2012 Edition).

Treatment strategy of stage Ⅰ non-small cell lung cancer before and after surgery

[China National Lung Cancer Screening Guideline with Low-dose Computed Tomography (2018 Version)].

Chinese Expert Consensus Workshop Report: Guideline for Permanent Iodine-125 Seeds Implantation of Primary and Metastatic Lung Tumors (2020 Edition)

Clinical Management of Gastric Cancer: Results of a Multicentre Survey